TLR4 and inflammatory bowel disease: Notably, rs5030728 in TLR4 was identified to be associated with subtherapeutic TLI in Spanish pediatric IBD (12), but all patients detected for rs5030728 were G allele carriers in our cohort, which might indicate a difference in pharmacogenetics among various populations.